WEBINAR with Verve Therapeutics: Design & develop gene therapies on a unified digital platform REGISTER
June 14, 2018
Benchmark Leads Benchling’s $14.5M Series B To Boost Life Sciences R&D

About Benchling

Benchling is the first R&D cloud platform powering the life science industry and helping the next generation of scientists make breakthrough discoveries and bring them to market faster than ever before. Multinational pharmaceutical corporations, high-growth biotechnology companies and major research institutions alike trust Benchling to speed collaboration and convert the complexity of life sciences into world-changing results.

Questions? [email protected]